Electrical stimulation system including a device for partially shielding electrical energy emitted from one or more electrical stimulation leads implanted in a human's body

• US 7,392,093 B2
• Filed: 09/24/2004
• Issued: 06/24/2008
• Est. Priority Date: 09/26/2003
• Status: Active Grant

• Current Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Inventors: Khan, Yasin N
• Primary Examiner(s): Layno; Carl H.
• Assistant Examiner(s): LEE, YUN HAENG NMN
• Application Number:
  US10/950,116
• Publication Number:
  US 20050137668A1
• Time in Patent Office: 1,369 Days
• Field of Search: 607/118, 128/899, 600/377
• US Class Current: 607/118
• CPC Class Codes: A61N 1/0553 Paddle shaped electrodes, e.g. for laminotomy
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/3718 Monitoring of or protection against external electromagnetic fields or currents

Abstract

In one embodiment, a device is provided for partially shielding electrical energy emitted from an electrical stimulation lead implanted in a human'"'"'s body to enable stimulation of the human'"'"'s nerve tissue, the lead including one or more electrodes operable to stimulate the nerve tissue. The device includes an anterior concave surface adapted to contact and at least partially surround a posterior side of the lead such that the lead is positioned between the anterior concave surface and the nerve tissue when the device and the lead are implanted in the body. The device includes a posterior convex surface coupled to the anterior concave surface and adapted to contact the body tissue opposite the nerve tissue. The device is adapted to partially shield electrical energy emitted from one or more electrodes on a posterior side of the lead when the device and the lead are implanted in the body to reduce a quantity of electrical energy reaching the body tissue opposite the nerve tissue.

Claims

1. A method of implanting first and second stimulation leads within the epidural space of a patient, comprising:

providing first and second percutaneous stimulation leads that each comprise a plurality of electrodes;

securing the first and second percutaneous stimulation leads within a device, the device being formed of a compressible material, and the device comprising;

(i) a first anterior concave surface adapted to contact and at least partially surround a posterior side of the first electrical stimulation lead;

(ii) a second anterior concave surface adapted to contact and at least partially surround a posterior side of the second electrical stimulation lead;

(iii) a posterior convex surface coupled to the first and second anterior concave surfaces; and

(iv) a lobe separating the first electrical stimulation lead and the second electrical stimulation lead;

the securing occurring by snapping the first and second percutaneous leads into the first and second anterior concave surfaces respectively;

inserting the device, with the first and second percutaneous leads secured thereto, through a needle into the epidural space of the patient, the device being compressed while proceeding through the needle, the device expanding upon entry into the epidural space of the patient to stabilize the first and second percutaneous stimulation leads in a side-by-side longitudinal arrangement within the epidural space of the patient;

electrically coupling the first and second stimulation leads to an implantable pulse generator (IPG); and

delivering stimulation pulses from the IPG to stimulate neural tissue of the patient using the first and second stimulation leads, wherein the first and second convex surfaces of the device partially shield electrical energy from the first and second stimulation leads.

2. The method of claim 1 wherein the device comprises a hollow interior.

3. The method of claim 2 wherein the hollow interior collapses when the device is inserted through the needle.

4. The method of claim 1 wherein the device comprises a solid interior.

5. The method of claim 1 wherein the device is formed of a polyurethane material.

6. The method of claim 1 wherein the device comprises a tapered trailing end for facilitating removal of the device, with the stimulation leads secured thereto, from the epidural space of the patient.